(Q34616633)

English

The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2010 on the treatment of acute bipolar depression

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2010 on the treatment of acute bipolar depression (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

0 references

biological psychiatry

1 reference

based on heuristic

inferred from title

bipolar depression

1 reference

based on heuristic

inferred from title

Siegfried Kasper

7

object named as

Siegfried Kasper

0 references

object named as

Heinz Grunze

1

0 references

object named as

Eduard Vieta

2

0 references

Hans-Jürgen Möller

6

object named as

Hans-Jürgen Möller

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

3

object named as

Guy M Goodwin

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

5

object named as

Rasmus W Licht

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

author name string

Charles Bowden

4

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

WFSBP Task Force On Treatment Guidelines For Bipolar Disorders

8

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

publication date

1 March 2010

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

World Journal of Biological Psychiatry

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

81-109

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Lithium in the treatment of acute depression

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Agitated "unipolar" depression re-conceptualized as a depressive mixed state: implications for the antidepressant-suicide controversy

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Gabapentin in the acute treatment of refractory bipolar disorder.

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Impact of antidepressant discontinuation after acute bipolar depression remission on rates of depressive relapse at 1-year follow-up

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Acceleration and augmentation strategies for treating bipolar depression

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Antidepressant monotherapy for bipolar type II major depression

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Efficacy and safety of fluoxetine in treating bipolar II major depressive episode.

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Switch from depression to mania--a record study over decades between 1920 and 1982.

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Do many patients with depression suffer from bipolar disorder?

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Depressive subtypes and efficacy of antidepressive pharmacotherapy

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Acute treatment of bipolar depression with adjunctive zonisamide: a retrospective chart review

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Decreased risk of suicides and attempts during long-term lithium treatment: a meta-analytic review

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders - first revision

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Lithium carbonate response in depression. Prediction by unipolar/bipolar illness, average-evoked response, catechol-O-methyl transferase, and family history

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Treatment of refractory depression with high-dose thyroxine.

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Supraphysiological doses of levothyroxine alter regional cerebral metabolism and improve mood in bipolar depression

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

The Bech-Rafaelsen Melancholia Scale (MES) in clinical trials of therapies in depressive disorders: a 20-year review of its use as outcome measure

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

An Inventory for Measuring Depression

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Agitated depression: a valid depression subtype?

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Mixed states in bipolar II disorder: should full hypomania always be required?

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Psychometric delineation of the most discriminant symptoms of depressive mixed states

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

How best to identify a bipolar-related subtype among major depressive patients without spontaneous hypomania: superiority of age at onset criterion over recurrence and polarity?

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

The Bipolar Depression Rating Scale (BDRS): its development, validation and utility.

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

N-acetyl cysteine for depressive symptoms in bipolar disorder--a double-blind randomized placebo-controlled trial

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Antidepressant-associated maniform states in acute treatment of patients with bipolar-I depression

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Valproate in bipolar disorder: 2000 onwards

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Safety and tolerability of lamotrigine for bipolar disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Placebo response in randomized controlled trials of antidepressants for pediatric major depressive disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Olanzapine/fluoxetine combination vs. lamotrigine in the 6-month treatment of bipolar I depression

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

The "switch process" in manic-depressive illness. I. A systematic study of sequential behavioral changes.

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Clinical studies on the use of lamotrigine in bipolar disorder.

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Controlled trials in bipolar I depression: focus on switch rates and efficacy

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Lamotrigine in the acute treatment of bipolar depression: results of five double-blind, placebo-controlled clinical trials

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

The clinical use of gabapentin in bipolar spectrum disorders

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

A perspective on the use of psychoeducation, cognitive-behavioral therapy and interpersonal therapy for bipolar patients

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Clinical factors associated with treatment noncompliance in euthymic bipolar patients

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Clinical and therapeutic implications of predominant polarity in bipolar disorder.

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Rate of switch from depression into mania after therapeutic sleep deprivation in bipolar depression

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

A 24-Week Open-Label Extension Study of Olanzapine-Fluoxetine Combination and Olanzapine Monotherapy in the Treatment of Bipolar Depression

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Safety and efficacy of Vagus Nerve Stimulation in treatment-resistant depression. A systematic review

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Divalproex in the treatment of bipolar depression: a placebo-controlled study

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Inositol augmentation of lithium or valproate for bipolar depression.

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Serum brain-derived neurotrophic factor in bipolar and unipolar depression: a potential adjunctive tool for differential diagnosis

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Treatment of bipolar depression: an update

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Efficacy of ethyl-eicosapentaenoic acid in bipolar depression: randomised double-blind placebo-controlled study

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Interpersonal and social rhythm therapy: a means of improving depression and preventing relapse in bipolar disorder.

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

A placebo-controlled evaluation of adjunctive modafinil in the treatment of bipolar depression

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Correlates of treatment-emergent mania associated with antidepressant treatment in bipolar depression.

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Antiepileptic drugs in mood-disordered patients

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Antipsychotic-induced extrapyramidal side effects in bipolar disorder and schizophrenia: a systematic review

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Lamotrigine for treatment of bipolar depression: independent meta-analysis and meta-regression of individual patient data from five randomised trials

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Pharmacological Treatment Patterns at Study Entry for the First 500 STEP-BD Participants.

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Long-term antidepressant treatment in bipolar disorder: meta-analyses of benefits and risks

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Early evidence on the effects of regulators' suicidality warnings on SSRI prescriptions and suicide in children and adolescents

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Antidepressants for bipolar depression: a systematic review of randomized, controlled trials

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Preliminary randomized, double-blind, placebo-controlled trial of pramipexole added to mood stabilizers for treatment-resistant bipolar depression

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Adjunctive antidepressant use and symptomatic recovery among bipolar depressed patients with concomitant manic symptoms: findings from the STEP-BD.

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Manic symptoms during depressive episodes in 1,380 patients with bipolar disorder: findings from the STEP-BD.

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Psychoeducation and cognitive-behavioral therapy in bipolar disorder: an update

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Vagus nerve stimulation in depression

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Lithium Response in Unipolar Versus Bipolar Depression

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

ECNP consensus meeting. Bipolar depression. Nice, March 2007.

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Lithium in the acute treatment of bipolar disorders-a stocktaking

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Relevance of new and newly rediscovered anticonvulsants for atypical forms of bipolar disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of bipolar disorders. Part I: Treatment of bipolar depression

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2009 on the treatment of acute mania

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Maintenance efficacy of divalproex in the prevention of bipolar depression

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Differences between subjective and objective assessments of the utility of Electroconvulsive therapy in patients with bipolar and unipolar depression.

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Development of a Rating Scale for Primary Depressive Illness

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Why olanzapine beats risperidone, risperidone beats quetiapine, and quetiapine beats olanzapine: an exploratory analysis of head-to-head comparison studies of second-generation antipsychotics

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Tranylcypromine versus imipramine in anergic bipolar depression

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Lamotrigine update and its use in mood disorders

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

N-desalkylquetiapine, a potent norepinephrine reuptake inhibitor and partial 5-HT1A agonist, as a putative mediator of quetiapine's antidepressant activity

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Psychotherapy of bipolar disorder: a review

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

The long-term natural history of the weekly symptomatic status of bipolar I disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Residual symptom recovery from major affective episodes in bipolar disorders and rapid episode relapse/recurrence

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Olanzapine: review of safety 2008

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Double-blind, randomized, placebo-controlled trials of ethyl-eicosapentanoate in the treatment of bipolar depression and rapid cycling bipolar disorder.

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Three times more days depressed than manic or hypomanic in both bipolar I and bipolar II disorder.

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

The poor prognosis of childhood-onset bipolar disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Commercial influence and the content of medical journals

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Pharmaceutical industry sponsorship and research outcome and quality: systematic review

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Validation of the Bech-Rafaelsen Melancholia Scale and the Hamilton Depression Scale in patients with major depression; is the total score a valid measure of illness severity?

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Are antidepressants safe in the treatment of bipolar depression? A critical evaluation of their potential risk to induce switch into mania or cycle acceleration

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Effectiveness of antipsychotic drugs in patients with chronic schizophrenia

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Efficacy of electroconvulsive therapy in treatment-resistant bipolar disorder: a case series.

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Agitated depression in bipolar I disorder: prevalence, phenomenology, and outcome

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

The functional impact of subsyndromal depressive symptoms in bipolar disorder: data from STEP-BD.

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Atypical antipsychotics in the treatment of affective symptoms: a review

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Do antidepressants work? A commentary on "Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration" by Kirsch et al.

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Olanzapine: a review of its use in the management of bipolar I disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Lithium revisited.

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Topiramate versus bupropion SR when added to mood stabilizer therapy for the depressive phase of bipolar disorder: a preliminary single-blind study

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Intensive psychosocial intervention enhances functioning in patients with bipolar depression: results from a 9-month randomized controlled trial

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Bipolar depression: phenomenological overview and clinical characteristics

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Diagnostic guidelines for bipolar depression: a probabilistic approach

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Isn't the efficacy of antidepressants clinically relevant? A critical comment on the results of the metaanalysis by Kirsch et al. 2008.

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Standardised rating scales in psychiatry: methodological basis, their possibilities and limitations and descriptions of important rating scales

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Double-blind multicenter study of paroxetine and amitriptyline in depressed inpatients

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Are antidepressants less effective in the acute treatment of bipolar I compared to unipolar depression?

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Do recent efficacy data on the drug treatment of acute bipolar depression support the position that drugs other than antidepressants are the treatment of choice? A conceptual review

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Do SSRIs or antidepressants in general increase suicidality? WPA Section on Pharmacopsychiatry: consensus statement

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

A New Depression Scale Designed to be Sensitive to Change

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Which antidepressants have demonstrated superior efficacy? A review of the evidence

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Left prefrontal transcranial magnetic stimulation (TMS) treatment of depression in bipolar affective disorder: a pilot study of acute safety and efficacy

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Double-blind, placebo-controlled comparison of imipramine and paroxetine in the treatment of bipolar depression

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

The effects of physical activity in the acute treatment of bipolar disorder: a pilot study.

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Treatment-resistant bipolar depression: a STEP-BD equipoise randomized effectiveness trial of antidepressant augmentation with lamotrigine, inositol, or risperidone

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Antidepressant monotherapy in pre-bipolar depression; predictive value and inherent risk

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

SSRIs as mood stabilizers for Bipolar II Disorder? A proof of concept study

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Industry sponsorship and financial conflict of interest in the reporting of clinical trials in psychiatry

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Clinical features of bipolar depression versus major depressive disorder in large multicenter trials

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Effectiveness of adjunctive gabapentin in resistant bipolar disorder: is it due to anxious-alcohol abuse comorbidity?

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

The birth of the bipolar disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

An overview of recent findings of the Stanley Foundation Bipolar Network (Part I).

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Mood switch in bipolar depression: comparison of adjunctive venlafaxine, bupropion and sertraline.

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Sleep and sleep-wake manipulations in bipolar depression

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Do antidepressants t(h)reat(en) depressives? Toward a clinically judicious formulation of the antidepressant-suicidality FDA advisory in light of declining national suicide statistics from many countries

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Australian and New Zealand clinical practice guidelines for the treatment of bipolar disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Vagus nerve stimulation (VNS) for treatment-resistant depressions: a multicenter study.

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Rationale, design, and methods of the systematic treatment enhancement program for bipolar disorder (STEP-BD).

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Effectiveness of adjunctive antidepressant treatment for bipolar depression

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Is the polarity of relapse/recurrence in bipolar-I disorder patients related to serum lithium levels? Results from an empirical study

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Moclobemide vs. imipramine in bipolar depression: a multicentre double-blind clinical trial

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

A review of acute treatments for bipolar depression

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Suicide risk during antidepressant treatment.

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Pharmacotherapy for bipolar disorder and comorbid conditions: baseline data from STEP-BD.

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Adjunctive quetiapine in bipolar patients partially responsive to lithium or valproate.

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Clinically significant pharmacokinetic drug interactions with carbamazepine. An update

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Quetiapine for the continuation treatment of bipolar depression: naturalistic prospective case series from the Stanley Bipolar Treatment Network

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Quetiapine for the treatment of bipolar II depression: analysis of data from two randomized, double-blind, placebo-controlled studies

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II study).

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Aripiprazole monotherapy in nonpsychotic bipolar I depression: results of 2 randomized, placebo-controlled studies

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

The International Society for Bipolar Disorders (ISBD) Task Force report on the nomenclature of course and outcome in bipolar disorders

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Self-Reported History of Manic/Hypomanic Switch Associated With Antidepressant Use

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Bipolar II disorder: arguments for and against a distinct diagnostic entity

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Adjunctive gabapentin treatment of bipolar disorder.

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Quetiapine monotherapy in the treatment of patients with bipolar I or II depression and a rapid-cycling disease course: a randomized, double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Bipolar disorder, antidepressants and induction of hypomania or mania. A systematic review

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Can antidepressants cause mania and worsen the course of affective illness?

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Zonisamide for bipolar depression

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Divalproex therapy in medication-naive and mood-stabilizer-naive bipolar II depression

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

The bipolar diathesis of treatment-resistant major depressive disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Rapid and sustained antidepressant response with sleep deprivation and chronotherapy in bipolar disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Adjunctive gabapentin in treatment-resistant depression: a retrospective chart review

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Comparative studies of the biological distinction between unipolar and bipolar depressions

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: update 2007.

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Lithium in maintenance therapy for bipolar disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Pramipexole for bipolar II depression: a placebo-controlled proof of concept study

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Adjunctive herbal medicine with carbamazepine for bipolar disorders: A double-blind, randomized, placebo-controlled study

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Suicide by antidepressant intoxication identified at autopsy in Vienna from 1991–1997: the favourable consequences of the increasing use of SSRIs

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Efficacy and Safety of Lamotrigine as Add-On Treatment to Lithium in Bipolar Depression

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Antidepressants in bipolar depression

1 reference

https://api.crossref.org/works/10.3109%2F15622970903555881

21 January 2018

Identifiers

10.3109/15622970903555881

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34616633&oldid=2066727822"